Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FRSW107 On-demand Treatment in Severe Hemophilia A
NCT07663903Phase 3Active, not recruiting
- Sponsor
- Gensciences
- Start
- Apr 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human coagulation factor viii-fc fusion protein in hemophilia A, sponsored by Gensciences. Started Apr 2026; status: active, not recruiting.
02
Drugs
recombinant human coagulation factor viii-fc fusion protein
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT07663903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07663903.